Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil

Clinical trials have shown the benefits of acetylcholinesterase inhibitors, such as donepezil and galantamine, and an N-methyl-D-aspartate receptor antagonist, memantine, in patients with Alzheimer’s disease (AD). However, little is known regarding the effects of switching from donepezil 5 mg/day to...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kano, Osamu, Ito, Hirono, Takazawa, Takanori, Kawase, Yuji, Murata, Kiyoko, Iwamoto, Konosuke, Nagaoka, Tetsuro, Hirayama, Takehisa, Miura, Ken, Nagata, Riya, Kiyozuka, Tetsuhito, Aoyagi, Jo, Sato, Ryuta, Eguchi, Teruo, Ikeda, Ken, Iwasaki, Yasuo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2013
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3575212/
https://ncbi.nlm.nih.gov/pubmed/23431041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S40682
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia